Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950753 · ClinicalTrials.gov registry record · Early Phase 1
Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?
A Early Phase 1 study of Hyperlactatemia, sponsored by University Medical Center of Southern Nevada.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02950753 is a Early Phase 1 study of Hyperlactatemia that has completed, run by University Medical Center of Southern Nevada. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02950753, a Early Phase 1 study of Hyperlactatemia, has completed, sponsored by University Medical Center of Southern Nevada.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Lactated Ringer's (LR) solution bolus is commonly administered in the emergency department setting to seriously ill patients. It is also common to obtain blood samples to determine serum lactate levels to aid in the assessment of the patient's degree of illness. This study endeavors to determine if serum lactate levels are affected by LR fluid administration in healthy adult individuals as compared to those who receive Normal Saline (NS). Healthy adult volunteers will be used as subjects so that the illness of hospital patients does not confound the results.
Conditions Studied
Interventions
- DRUG Normal Saline
- DRUG Lactated Ringer Solution
Study Locations (1)
Nevada
- University Medical Center of Southern Nevada - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-01-04 |
| Est. Completion | 2017-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950753
The ClinicalTrials.gov registry entry for NCT02950753 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Medical Center of Southern Nevada, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperlactatemia appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.
NCT02950753 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT02950753 about?
NCT02950753 is a clinical study titled "Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?". Lactated Ringer's (LR) solution bolus is commonly administered in the emergency department setting to seriously ill patients. It is also common to obtain blood samples to determine serum lactate levels to aid in the assessment of the patient's degree of illness. This study endeavors to determine if ...
What is the current status of trial NCT02950753?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2017-01-04. Estimated completion is 2017-06-01.
What conditions does trial NCT02950753 study?
This clinical trial studies the following conditions: Hyperlactatemia.
What interventions are being tested in trial NCT02950753?
The interventions under investigation include: Normal Saline (DRUG), Lactated Ringer Solution (DRUG).
Who is sponsoring clinical trial NCT02950753?
This trial is sponsored by University Medical Center of Southern Nevada, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02950753 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.